Action of SARS CoV2 in Human Brain Cultures
SARS CoV2 在人脑培养物中的作用
基本信息
- 批准号:10173327
- 负责人:
- 金额:$ 54.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAcute respiratory failureAffectAgeAlzheimer&aposs DiseaseAmyloid beta-ProteinAstrocytesBlood VesselsBlood capillariesBrainBrain regionCOVID-19CardiopulmonaryCellsCessation of lifeChinaClinicalConfusionDiseaseDrug TargetingEncephalitisEventFutureGene ExpressionGenetic TranscriptionGuillain-Barré SyndromeHeadacheHeart failureHumanInfectionInflammasomeInflammationInjuryLeadMeningitisMicrogliaMusNauseaNerve DegenerationNervous System PhysiologyNervous system structureNeurogliaNeurologic SymptomsNeuronsNoseOrganoidsOutcomeParkinson DiseasePathologicPatientsPeptidyl-Dipeptidase APredispositionProteinsReactionReportingRespirationRespiratory Signs and SymptomsRespiratory physiologyRisk FactorsRoleRouteSARS coronavirusSeizuresSmell PerceptionStrokeStructure of parenchyma of lungTaste PerceptionTestingTherapeuticTissuesTropismUnconscious StateVirusalpha synucleinbrain cellcell injuryheart functionimprovedinduced pluripotent stem cellinsightmind controlmisfolded proteinneuron lossneurotoxicityprogramsrelating to nervous systemresponsesingle-cell RNA sequencingtau Proteins
项目摘要
PROJECT SUMMARY
There is emerging evidence that SARS-CoV2 or COVID19 gains entry into human brain cells leading to a
sequela of neurologic symptoms. There is concern that SARS-CoV2 may lead to neurotoxicity and that
neuronal death in the regions of the brain that control respiration and cardiac function may be a contributing
factor to the acute loss of cardio respiratory function and death. SARS-CoV2 could gain access to the brain by
several routes including through the nose, or neurons innervating infected lung tissue or through the cells lining
blood capillaries in the brain. COVID-19 patients lose their sense of smell or taste often before the onset of
respiratory symptoms and a patient presented with Guillain-Barré syndrome before testing positive for SARS-
CoV2. It appears that at least 36% of COVID19 patients had neurologic manifestations including headache,
nausea, loss of consciousness, strokes, confusion, encephalitis, meningitis and seizures. These clinical
observations strongly indicate a role for SARS-CoV2 in the death of neurons and importantly the brain may be
one of the first tissues infected and affected. The actions of SARS-CoV2 on the different cells in the brain, as
well as the infectivity, tropism, and replication in brain cells is not yet known. In this application we propose to
evaluate: (1) The tropism and replication of SARS-CoV2 in human microglia, astrocytes, neurons, and
determine relative susceptibility? (2) The mechanisms of cellular injury and evaluate potential protective
approaches. (3) Determine the transcriptional responses to SARS CoV2 infection in human neurons,
astrocytes, and microglia at the single cell level to gain new insight into the differential response of brain cells
to SARS CoV2 to better understand the neural deficits the virus causes.
项目概要
有新的证据表明 SARS-CoV2 或 COVID19 进入人类脑细胞,导致
神经系统症状的后遗症。人们担心 SARS-CoV2 可能会导致神经毒性,并且
控制呼吸和心脏功能的大脑区域的神经元死亡可能是一个促成因素
导致心肺功能急性丧失和死亡的因素。 SARS-CoV2 可以通过以下方式进入大脑:
多种途径,包括通过鼻子或神经元支配受感染的肺组织或通过细胞内壁
大脑中的毛细血管。 COVID-19 患者在发病前经常失去嗅觉或味觉
呼吸道症状和一名在 SARS 检测呈阳性之前出现格林-巴利综合征的患者
冠状病毒2。至少 36% 的新冠肺炎患者出现神经系统症状,包括头痛、
恶心、意识丧失、中风、精神错乱、脑炎、脑膜炎和癫痫发作。这些临床
观察结果强烈表明 SARS-CoV2 在神经元死亡中发挥作用,重要的是大脑可能
最先被感染和受影响的组织之一。 SARS-CoV2 对大脑中不同细胞的作用,如
以及脑细胞中的感染性、趋向性和复制性尚不清楚。在此应用中,我们建议
评估:(1) SARS-CoV2 在人类小胶质细胞、星形胶质细胞、神经元和细胞中的趋向性和复制
确定相对敏感性 ? (2)细胞损伤机制及潜在保护作用评价
接近。 (3)确定人类神经元对SARS CoV2感染的转录反应,
单细胞水平的星形胶质细胞和小胶质细胞,以获得对脑细胞差异反应的新见解
SARS CoV2,以更好地了解该病毒引起的神经缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALINA L. DAWSON其他文献
VALINA L. DAWSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALINA L. DAWSON', 18)}}的其他基金
Innate immune memory promotes neural damage in the ART suppressed HIV infected brain
先天免疫记忆促进 ART 抑制的 HIV 感染大脑中的神经损伤
- 批准号:
10701935 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain
基于成像质谱的阿尔茨海默病大脑代谢组学分析
- 批准号:
10516253 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:
Innate immune memory promotes neural damage in the ART suppressed HIV infected brain
先天免疫记忆促进 ART 抑制的 HIV 感染大脑中的神经损伤
- 批准号:
10536461 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain
基于成像质谱的阿尔茨海默病大脑代谢组学分析
- 批准号:
10705238 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:
Targeting cell signaling pathways to disrupt drug abuse
靶向细胞信号通路以破坏药物滥用
- 批准号:
10404512 - 财政年份:2018
- 资助金额:
$ 54.26万 - 项目类别:
Thorase Regulation of the Actions of Cocaine
Thorase 对可卡因作用的调节
- 批准号:
10404517 - 财政年份:2018
- 资助金额:
$ 54.26万 - 项目类别:
Targeting cell signaling pathways to disrupt drug abuse
靶向细胞信号通路以破坏药物滥用
- 批准号:
10171821 - 财政年份:2018
- 资助金额:
$ 54.26万 - 项目类别:
Thorase Regulation of the Actions of Cocaine
Thorase 对可卡因作用的调节
- 批准号:
10171826 - 财政年份:2018
- 资助金额:
$ 54.26万 - 项目类别:
Characterization of a novel Flpo recombinase line targeting nigral dopamine neurons
靶向黑质多巴胺神经元的新型 Flpo 重组酶系的表征
- 批准号:
9434206 - 财政年份:2017
- 资助金额:
$ 54.26万 - 项目类别:
相似海外基金
Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
- 批准号:
10633823 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
- 批准号:
10724042 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
- 批准号:
10739060 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
- 批准号:
10731311 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
- 批准号:
10622756 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
- 批准号:
10732929 - 财政年份:2023
- 资助金额:
$ 54.26万 - 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
- 批准号:
10413457 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
- 批准号:
10313769 - 财政年份:2022
- 资助金额:
$ 54.26万 - 项目类别:














{{item.name}}会员




